New eye drops offer hope for rare corneal condition
Disease control
AVAILABLE
This program provides access to BRM421 eye drops for adults with mild to moderate limbal stem cell deficiency (LSCD) who are not satisfied with standard treatments. Participants use the drops twice a day for at least 12 weeks and visit the clinic monthly for checkups. The goal is…
Sponsor: BRIM Biotechnology Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC